A Pilot Study of the Effectiveness of a Short Course of Rifaximin 2200 mg/day on Abdominal Symptoms and its Effects on Quality of Life in Patients with Moderate to Severe Diarrhea-Predominant Irritable Bowel Syndrome
Clinical Drug Investigation · 2024
DOI: 10.1007/s40261-024-01403-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Drug Investigation, 2024. Verfasst von Marjan Mokhtare und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology, Internal Medicine Department, School of Medicine, Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Niya…. Hauptthemen laut MEDLINE: Rifaximin, Irritable Bowel Syndrome, Quality of Life, Diarrhea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Gastroenterology and Hepatology, Internal Medicine Department, School of Medicine, Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Niyayesh St., Sattarkhan Ave., Tehran, Iran. marjanmokhtare@yahoo.com.
- Gastroenterology and Hepatology, Internal Medicine Department, School of Medicine, Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Niyayesh St., Sattarkhan Ave., Tehran, Iran.
- School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Physiology Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Mokhtare, M., Fathi, M., Sadeghian, A. M., Sotoudeheian, M. J., & Namazi, A. (2024). A Pilot Study of the Effectiveness of a Short Course of Rifaximin 2200 mg/day on Abdominal Symptoms and its Effects on Quality of Life in Patients with Moderate to Severe Diarrhea-Predominant Irritable Bowel Syndrome. Clinical Drug Investigation. https://doi.org/10.1007/s40261-024-01403-w
Vancouver
Mokhtare M, Fathi M, Sadeghian AM, Sotoudeheian MJ, Namazi A. A Pilot Study of the Effectiveness of a Short Course of Rifaximin 2200 mg/day on Abdominal Symptoms and its Effects on Quality of Life in Patients with Moderate to Severe Diarrhea-Predominant Irritable Bowel Syndrome. Clinical Drug Investigation. 2024. doi:10.1007/s40261-024-01403-w
BibTeX
@article{Mokhtare2024,
author = {Mokhtare, Marjan and Fathi, Maryam and Sadeghian, Amir M and Sotoudeheian, Mohammad-Javad and Namazi, Abolfazl},
title = {A Pilot Study of the Effectiveness of a Short Course of Rifaximin 2200 mg/day on Abdominal Symptoms and its Effects on Quality of Life in Patients with Moderate to Severe Diarrhea-Predominant Irritable Bowel Syndrome},
journal = {Clinical Drug Investigation},
year = {2024},
doi = {10.1007/s40261-024-01403-w}
}
EUVIMED